Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B ROTHMAN

Showing results (511-520 of 606) with videos related to

Pageof 61
Sort By:
Neuropharmacology|September 1, 1990
Specificity of phencyclidine-like drugs and benzomorphan opiates for two high affinity phencyclidine binding sites in guinea pig brainA A Reid, M V Mattson, B R de Costa, et al.
Neuropharmacology|December 1, 1989
A study of the interaction of the alkylating agent, NIH10236, with opioid receptors in vitro and in vivoR B Rothman, J B Long, J W Holaday, et al.
Neurochemical Research|February 1, 1994
Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domainsC M Dersch, H C Akunne, J S Partilla, et al.
Trends in Pharmacological Sciences|March 1, 1992
A proposal for the classification of sigma binding sitesR Quirion, W D Bowen, Y Itzhak, et al.
Molecular Immunology|April 26, 2011
Fyn binds to and phosphorylates T cell immunoglobulin and mucin domain-1 (Tim-1)Miranda L Curtiss, Bruce S Hostager, Elizabeth Stepniak, et al.
Bioorganic & Medicinal Chemistry|March 28, 2006
Structure-activity relationships of substituted N-benzyl piperidines in the GBR series: Synthesis of 4-(2-(bis(4-fluorophenyl)methoxy)ethyl)-1-(2-trifluoromethylbenzyl)piperidine, an allosteric modulator of the serotonin transporterTerrence L Boos, Elisabeth Greiner, W Jason Calhoun, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2003
In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substratesRichard B Rothman, Nga Vu, John S Partilla, et al.
Cell Reports|January 20, 2021
Critical role of Syk-dependent STAT1 activation in innate antiviral immunityShasha Liu, Yuan Liao, Biao Chen, et al.
Brain Research Bulletin|July 22, 2008
Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptorsHeng Xu, Xiaoying Wang, John S Partilla, et al.
Regulatory Peptides|October 20, 1995
Opioid peptide receptor studies. 4. Antisense oligodeoxynucleotide to the delta opioid receptor delineates opioid receptor subtypesX Y Cha, H Xu, Q Ni, et al.
Pageof 61

Showing results (511-520 of 606) with videos related to

Sort By:
Pageof 61
Neuropharmacology|September 1, 1990
Specificity of phencyclidine-like drugs and benzomorphan opiates for two high affinity phencyclidine binding sites in guinea pig brainA A Reid, M V Mattson, B R de Costa, et al.
Neuropharmacology|December 1, 1989
A study of the interaction of the alkylating agent, NIH10236, with opioid receptors in vitro and in vivoR B Rothman, J B Long, J W Holaday, et al.
Neurochemical Research|February 1, 1994
Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domainsC M Dersch, H C Akunne, J S Partilla, et al.
Trends in Pharmacological Sciences|March 1, 1992
A proposal for the classification of sigma binding sitesR Quirion, W D Bowen, Y Itzhak, et al.
Molecular Immunology|April 26, 2011
Fyn binds to and phosphorylates T cell immunoglobulin and mucin domain-1 (Tim-1)Miranda L Curtiss, Bruce S Hostager, Elizabeth Stepniak, et al.
Bioorganic & Medicinal Chemistry|March 28, 2006
Structure-activity relationships of substituted N-benzyl piperidines in the GBR series: Synthesis of 4-(2-(bis(4-fluorophenyl)methoxy)ethyl)-1-(2-trifluoromethylbenzyl)piperidine, an allosteric modulator of the serotonin transporterTerrence L Boos, Elisabeth Greiner, W Jason Calhoun, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2003
In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substratesRichard B Rothman, Nga Vu, John S Partilla, et al.
Cell Reports|January 20, 2021
Critical role of Syk-dependent STAT1 activation in innate antiviral immunityShasha Liu, Yuan Liao, Biao Chen, et al.
Brain Research Bulletin|July 22, 2008
Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptorsHeng Xu, Xiaoying Wang, John S Partilla, et al.
Regulatory Peptides|October 20, 1995
Opioid peptide receptor studies. 4. Antisense oligodeoxynucleotide to the delta opioid receptor delineates opioid receptor subtypesX Y Cha, H Xu, Q Ni, et al.
Pageof 61